Open access
2026
Tb-labeled bisphosphonates as potential agents for bone-targeted radiotherapy
Radiopharmaceutical therapy using bone-targeting agents labeled with β-emitting radionuclides has proven effective for pain palliation and disease management. This study aimed to develop 161Tb-labeled bisphosphonates with high radiolabeling yield, in vitro stability, and appropriate biodistribution. Etidronate and zole...
P. Sitarica, A. Vukadinović, M. Perić et al.
· Zbornik radova · 0 citations